Parallel to Nakamura et al., Toyoda et al. compared AFP, AFP-L3 and DCP regarding HCC prognosis and reported that AFP-L3 and DCP likely mirror different features of HCC progression, prediction of patient outcome, and treatment efficacy [26]. Here, AFP is linked to hepatocellular carcinoma.